Compare EBS & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EBS | NBBK |
|---|---|---|
| Founded | 1998 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.3M | 718.5M |
| IPO Year | 2006 | N/A |
| Metric | EBS | NBBK |
|---|---|---|
| Price | $13.20 | $19.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $15.00 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 788.6K | 216.7K |
| Earning Date | 10-29-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 1.40% |
| EPS Growth | N/A | ★ 420.99 |
| EPS | 1.35 | ★ 1.54 |
| Revenue | ★ $788,900,000.00 | $189,481,000.00 |
| Revenue This Year | N/A | $43.56 |
| Revenue Next Year | $15.21 | $23.60 |
| P/E Ratio | ★ $9.51 | $12.94 |
| Revenue Growth | N/A | ★ 30.69 |
| 52 Week Low | $4.02 | $15.09 |
| 52 Week High | $13.41 | $21.58 |
| Indicator | EBS | NBBK |
|---|---|---|
| Relative Strength Index (RSI) | 67.74 | 46.25 |
| Support Level | $12.02 | $19.37 |
| Resistance Level | $12.90 | $20.53 |
| Average True Range (ATR) | 0.50 | 0.50 |
| MACD | 0.00 | -0.21 |
| Stochastic Oscillator | 75.00 | 27.44 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.